<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ADilution</id>
	<title>Definition:Dilution - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ADilution"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Dilution&amp;action=history"/>
	<updated>2026-04-30T02:11:56Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Dilution&amp;diff=17013&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Dilution&amp;diff=17013&amp;oldid=prev"/>
		<updated>2026-03-15T10:00:57Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📉 &amp;#039;&amp;#039;&amp;#039;Dilution&amp;#039;&amp;#039;&amp;#039; in the insurance and insurtech context refers to the reduction in existing shareholders&amp;#039; ownership percentage — and potentially the per-share value of their holdings — when a company issues additional equity, whether through a new funding round, public offering, stock-based compensation plan, or conversion of convertible instruments. For insurtech startups progressing through successive venture capital rounds, dilution is an ever-present consideration, as each Series A, B, or C financing typically introduces new investors who receive shares in exchange for capital, thereby reducing the proportional stake of founders, employees, and earlier investors. Established [[Definition:Insurance carrier | insurance carriers]] and [[Definition:Reinsurance | reinsurers]] listed on public exchanges also face dilution dynamics when they raise equity capital — often following large [[Definition:Catastrophe loss | catastrophe losses]] or to fund acquisitions.&lt;br /&gt;
&lt;br /&gt;
⚙️ The mechanics of dilution depend on the valuation at which new shares are issued relative to the company&amp;#039;s existing value. If an [[Definition:Insurtech | insurtech]] firm valued at $100 million issues $25 million in new equity, the founders&amp;#039; percentage ownership decreases proportionally, though the absolute value of their shares may hold steady or increase if the new capital accelerates growth. Dilution becomes particularly contentious in &amp;quot;down rounds,&amp;quot; where shares are issued at a lower valuation than the previous funding event — a scenario several insurtechs faced during the market correction of the early 2020s after years of elevated valuations. Anti-dilution provisions in [[Definition:Preferred stock | preferred stock]] agreements, such as weighted-average or full-ratchet protections, are commonly negotiated by venture investors to shield their stakes from excessive erosion. For publicly traded insurers, share buyback programs serve as a counterbalancing tool: companies like [[Definition:AIG | AIG]] and [[Definition:Zurich Insurance Group | Zurich]] have deployed [[Definition:Excess capital | excess capital]] to repurchase shares, effectively reversing dilution and returning value to remaining shareholders.&lt;br /&gt;
&lt;br /&gt;
💡 Understanding dilution is essential for anyone evaluating the capital structure and growth trajectory of insurance enterprises — whether a Series B insurtech raising capital to scale distribution or a legacy carrier tapping equity markets after a severe loss year. Founders and management teams in the insurtech space must balance the need for growth capital against the erosion of their economic interest and voting control, a tension that shapes negotiation dynamics with [[Definition:Venture capital | venture capital]] and [[Definition:Private equity | private equity]] investors at every stage. For analysts and investors assessing publicly listed insurers, dilution from convertible debt issuances or employee stock option programs can meaningfully affect [[Definition:Earnings per share (EPS) | earnings per share]] calculations and, consequently, market valuations. In an industry where capital adequacy directly determines an insurer&amp;#039;s ability to write business and maintain regulatory standing, the decision of when and how much equity to issue — and the dilution it entails — is among the most consequential strategic choices management can make.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Equity financing]]&lt;br /&gt;
* [[Definition:Venture capital]]&lt;br /&gt;
* [[Definition:Initial public offering (IPO)]]&lt;br /&gt;
* [[Definition:Excess capital]]&lt;br /&gt;
* [[Definition:Share buyback]]&lt;br /&gt;
* [[Definition:Capital management]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>